INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹1.36 Cr | ₹4.24 Cr | ₹36 Cr | ₹40 Cr | ₹23 Cr |
What is the latest Contingent Liabilities ratio of INDSWIFT LABORATORIES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹1.36 Cr |
Mar2023 | ₹4.24 Cr |
Mar2022 | ₹36 Cr |
Mar2021 | ₹40 Cr |
Mar2020 | ₹23 Cr |
How is Contingent Liabilities of INDSWIFT LABORATORIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1.36 Cr | -68.05 | |
Mar2023 | ₹4.24 Cr | -88.11 | |
Mar2022 | ₹36 Cr | -11.00 | |
Mar2021 | ₹40 Cr | 75.55 | |
Mar2020 | ₹23 Cr | - |
Compare Contingent Liabilities of peers of INDSWIFT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDSWIFT LABORATORIES | ₹760.6 Cr | 1% | -6.5% | -24.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,273.0 Cr | 2.5% | 4.1% | -0.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,604.0 Cr | 0.5% | -2.9% | 35.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,316.0 Cr | 6.2% | 9.3% | 17.9% | Stock Analytics | |
CIPLA | ₹125,993.0 Cr | 4.9% | 2.9% | 1.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,795.0 Cr | 2.1% | 1.2% | -5% | Stock Analytics |
INDSWIFT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDSWIFT LABORATORIES | 1% |
-6.5% |
-24.9% |
SENSEX | -1.5% |
-2.5% |
0.2% |
You may also like the below Video Courses